Pages that link to "Q86497271"

The following pages link to In vivo PET imaging demonstrates diminished microglial activation after fingolimod treatment in an animal model of multiple sclerosis (Q86497271):

Displaying 49 items.

• Double Roles of Macrophages in Human Neuroimmune Diseases and Their Animal Models (Q26749131) (← links)
• Precision Medicine in Multiple Sclerosis: Future of PET Imaging of Inflammation and Reactive Astrocytes (Q28078621) (← links)
• Imaging neuroinflammation in multiple sclerosis using TSPO-PET (Q28084625) (← links)
• Exploring the role of microglia in mood disorders associated with experimental multiple sclerosis (Q35777988) (← links)
• Lipoic acid reduces inflammation in a mouse focal cortical experimental autoimmune encephalomyelitis model (Q36333347) (← links)
• In vivo PET imaging of the neuroinflammatory response in rat spinal cord injury using the TSPO tracer [(18)F]GE-180 and effect of docosahexaenoic acid (Q37063225) (← links)
• Imaging of neuroinflammation in Alzheimer's disease, multiple sclerosis and stroke: Recent developments in positron emission tomography (Q38661497) (← links)
• Imaging Microglial Activation with TSPO PET: Lighting Up Neurologic Diseases? (Q38677275) (← links)
• Prospective clinical trials to investigate clinical and molecular biomarkers. (Q38694561) (← links)
• Immune-mediated processes in neurodegeneration: where do we stand? (Q38731476) (← links)
• FTY720 (fingolimod) regulates key target genes essential for inflammation in microglial cells as defined by high-resolution mRNA sequencing. (Q38735557) (← links)
• Evaluation of the effect of fingolimod treatment on microglial activation using serial PET imaging in multiple sclerosis. (Q38740624) (← links)
• Imaging of microglial activation in MS using PET: Research use and potential future clinical application. (Q38808948) (← links)
• The immune response of the human brain to abdominal surgery (Q38933080) (← links)
• Molecular imaging of neuroinflammation in preclinical rodent models using positron emission tomography. (Q39011885) (← links)
• WONOEP appraisal: Imaging biomarkers in epilepsy (Q39018707) (← links)
• Comparative Evaluation of Three TSPO PET Radiotracers in a LPS-Induced Model of Mild Neuroinflammation in Rats (Q39535676) (← links)
• Fingolimod: A Disease-Modifier Drug in a Mouse Model of Amyotrophic Lateral Sclerosis. (Q39561307) (← links)
• Effect of Preventive and Curative Fingolimod Treatment Regimens on Microglia Activation and Disease Progression in a Rat Model of Multiple Sclerosis (Q41125322) (← links)
• Maternal immune activation results in complex microglial transcriptome signature in the adult offspring that is reversed by minocycline treatment. (Q41173167) (← links)
• Serial Quantitative TSPO-Targeted PET Reveals Peak Microglial Activation up to 2 Weeks After an Epileptogenic Brain Insult. (Q45750422) (← links)
• Neuroinflammation imaging markers for epileptogenesis. (Q46360384) (← links)
• Effects of the Positive Allosteric Modulator of Metabotropic Glutamate Receptor 5, VU-29, on Impairment of Novel Object Recognition Induced by Acute Ethanol and Ethanol Withdrawal in Rats (Q47237998) (← links)
• Fingolimod anti-inflammatory and neuroprotective effects modulation of RAGE axis in multiple sclerosis patients (Q47338812) (← links)
• Neuroinflammation appears early and then plateaus in a mouse model of Alzheimer's disease shown by PET imaging (Q47684673) (← links)
• In Vivo Detection of Age- and Disease-Related Increases in Neuroinflammation by 18F-GE180 TSPO MicroPET Imaging in Wild-Type and Alzheimer's Transgenic Mice. (Q48097928) (← links)
• Neuroimaging techniques to assess inflammation in Multiple Sclerosis. (Q48170522) (← links)
• Effect of fingolimod on diffuse brain tissue damage in relapsing-remitting multiple sclerosis patients (Q48708458) (← links)
• In vivo imaging of system xc- as a novel approach to monitor multiple sclerosis (Q49160094) (← links)
• 18F-VC701-PET and MRI in the in vivo neuroinflammation assessment of a mouse model of multiple sclerosis (Q49605374) (← links)
• Neuroinflammation following disease modifying therapy in multiple sclerosis: A pilot positron emission tomography study (Q50180682) (← links)
• Evaluation of Microglial Activation in Multiple Sclerosis Patients Using Positron Emission Tomography. (Q52597663) (← links)
• The roles of macrophages and microglia in multiple sclerosis and experimental autoimmune encephalomyelitis. (Q52615341) (← links)
• Connections of annexin A1 and translocator protein-18 kDa on toll like receptor stimulated BV-2 cells. (Q54205666) (← links)
• The Place of PET to Assess New Therapeutic Effectiveness in Neurodegenerative Diseases. (Q55020340) (← links)
• Vascular adhesion protein-1 is actively involved in the development of inflammatory lesions in rat models of multiple sclerosis. (Q55399614) (← links)
• Neuroinflammation in Neurodegenerative Diseases: Current Multi-modal Imaging Studies and Future Opportunities for Hybrid PET/MRI (Q57174187) (← links)
• Expression of Translocator Protein and [18F]-GE180 Ligand Uptake in Multiple Sclerosis Animal Models (Q64245099) (← links)
• Cessation of anti-VLA-4 therapy in a focal rat model of multiple sclerosis causes an increase in neuroinflammation (Q64245341) (← links)
• TSPO-PET imaging using [18F]PBR06 is a potential translatable biomarker for treatment response in Huntington's disease: preclinical evidence with the p75NTR ligand LM11A-31 (Q88960978) (← links)
• 18F-FAC PET visualizes brain-infiltrating leukocytes in a mouse model of multiple sclerosis (Q90949578) (← links)
• Laquinimod ameliorates secondary brain inflammation (Q91297371) (← links)
• Folate receptor-targeted positron emission tomography of experimental autoimmune encephalomyelitis in rats (Q91651206) (← links)
• A Path Toward Precision Medicine for Neuroinflammatory Mechanisms in Alzheimer's Disease (Q91973479) (← links)
• Quantifying disease activity in rheumatoid arthritis with the TSPO PET ligand 18F-GE-180 and comparison with 18F-FDG and DCE-MRI (Q92136836) (← links)
• PET Evaluation of Microglial Activation in Non-neurodegenerative Brain Diseases (Q92363662) (← links)
• Protein phosphatase 2A as a therapeutic target in inflammation and neurodegeneration (Q92489253) (← links)
• Fingolimod Inhibits Inflammation but Exacerbates Brain Edema in the Acute Phases of Cerebral Ischemia in Diabetic Mice (Q98734107) (← links)
• Oligodendrocyte Lineage Marker Expression in eGFP-GFAP Transgenic Mice (Q112747131) (← links)